TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
CGC

Canopy Growth Corp

Healthcare · Drug Manufacturers - Specialty & Generic

0.8845$ +1.0% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Canopy Growth Corp (CGC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Total Assets" came in at 1,119 million CAD. Tick rows to compare them in a chart.

All figures in millions of CAD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet CGC
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
48 143 678 1,437 8,732 4,818 6,823 5,605 2,440 1,300 918 1,119
29 45 179 482 4,919 1,802 2,838 1,728 1,077 371 295 529
21 15 102 323 2,481 916 1,155 776 668 170 114 365
21 15 102 323 4,544 1,404 2,318 1,372 773 203 131 371
0.3 1.5 5.8 21 107 63 67 87 68 52 53 36
6.4 22 61 118 190 275 369 205 83 77 96 154
14 44 96 304 1,096 1,525 1,075 943 – – – –
0.0 21 241 315 1,544 1,373 1,889 1,867 86 43 46 78
0.3 32 162 102 520 335 308 253 161 104 87 129
6.4 20 63 194 1,490 1,180 3,202 1,985 1,680 800 430 421
4.5 7.2 18 92 412 295 284 213 804 235 94 158
0.2 0.6 1.7 1.6 104 40 52 47 585 119 21 31
4.1 5.9 5.7 46 189 87 67 64 32 29 26 35
1.3 3.5 8.6 6.9 842 449 1,573 1,492 750 493 300 217
41 124 640 1,159 6,780 3,433 3,482 3,584 758 500 487 698
-10 -14 -21 -92 -835 -3,037 -6,068 -6,378 -9,673 -10,330 -10,928 -11,138
30 77 119 177 338 356 376 39 46 75 108 2,980

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?